Expression of HMMR is upregulated in a variety of cancers, such as colorectal cancer 8, stomach cancer 9, endometrial cancer 10, prostate cancer 11, and multiple myeloma 12, and its high expression correlates with poor prognosis. Here, HMMR is linked to gastric cancer.